IL90189A0 - Pharmaceutical compositions containing a benzazepine-type calcium channel blocker - Google Patents
Pharmaceutical compositions containing a benzazepine-type calcium channel blockerInfo
- Publication number
- IL90189A0 IL90189A0 IL90189A IL9018989A IL90189A0 IL 90189 A0 IL90189 A0 IL 90189A0 IL 90189 A IL90189 A IL 90189A IL 9018989 A IL9018989 A IL 9018989A IL 90189 A0 IL90189 A0 IL 90189A0
- Authority
- IL
- Israel
- Prior art keywords
- benzazepine
- pharmaceutical compositions
- compositions containing
- calcium channel
- channel blocker
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20317388A | 1988-06-01 | 1988-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL90189A0 true IL90189A0 (en) | 1989-12-15 |
Family
ID=22752815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL90189A IL90189A0 (en) | 1988-06-01 | 1989-05-04 | Pharmaceutical compositions containing a benzazepine-type calcium channel blocker |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0344995A3 (da) |
JP (1) | JPH0225422A (da) |
KR (1) | KR900000082A (da) |
AU (1) | AU607612B2 (da) |
DK (1) | DK265789A (da) |
HU (1) | HUT58521A (da) |
IL (1) | IL90189A0 (da) |
ZA (1) | ZA893735B (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6162802A (en) * | 1992-03-10 | 2000-12-19 | Papa; Joseph | Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor |
US6300085B1 (en) | 1993-05-03 | 2001-10-09 | The United States Of America As Represented By The Department Of Health And Human Services | Diagnostic method for Alzheimer's disease |
US5976816A (en) * | 1993-05-03 | 1999-11-02 | The United States Of America As Represented By The Department Of Health And Human Services | Cell tests for alzheimer's disease |
MXPA02006352A (es) * | 2000-01-26 | 2002-11-29 | Warner Lambert Co | Combinaciones del inhibidor ace con el antagonista vasopresina. |
US20030008860A1 (en) | 2002-05-09 | 2003-01-09 | Bakker-Arkema Rebecca Guggemos | Treatment of congestive heart failure |
JPWO2005011736A1 (ja) * | 2003-07-30 | 2006-09-14 | 株式会社 東北テクノアーチ | アルツハイマー病の予防および/または治療剤 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4105776A (en) * | 1976-06-21 | 1978-08-08 | E. R. Squibb & Sons, Inc. | Proline derivatives and related compounds |
US4168267A (en) * | 1978-10-23 | 1979-09-18 | E. R. Squibb & Sons, Inc. | Phosphinylalkanoyl prolines |
IL58849A (en) * | 1978-12-11 | 1983-03-31 | Merck & Co Inc | Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them |
US4432971A (en) * | 1981-08-03 | 1984-02-21 | E. R. Squibb & Sons, Inc. | Phosphonamidate compounds |
US4452790A (en) * | 1982-06-23 | 1984-06-05 | E. R. Squibb & Sons, Inc. | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives |
US4504476A (en) * | 1983-09-16 | 1985-03-12 | Arnold Schwartz | Method of administering calcium channel blocking agents |
US4748239A (en) * | 1985-06-12 | 1988-05-31 | E. R. Squibb & Sons, Inc. | Benzazepine derivatives |
FR2607004B1 (fr) * | 1986-11-20 | 1990-06-01 | Synthelabo | Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine |
AU612137B2 (en) * | 1987-04-27 | 1991-07-04 | E.R. Squibb & Sons, Inc. | Method for inhibiting loss of cognitive functions employing an ace inhibitor |
US4871731A (en) * | 1987-10-07 | 1989-10-03 | Marion Laboratories, Inc. | Captopril and diltiazem composition and the like |
-
1989
- 1989-05-04 IL IL90189A patent/IL90189A0/xx unknown
- 1989-05-18 ZA ZA893735A patent/ZA893735B/xx unknown
- 1989-05-18 AU AU34930/89A patent/AU607612B2/en not_active Ceased
- 1989-05-26 EP EP19890305386 patent/EP0344995A3/en not_active Ceased
- 1989-05-31 HU HU892789A patent/HUT58521A/hu unknown
- 1989-05-31 KR KR1019890007407A patent/KR900000082A/ko not_active Application Discontinuation
- 1989-05-31 DK DK265789A patent/DK265789A/da not_active Application Discontinuation
- 1989-06-01 JP JP1140236A patent/JPH0225422A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU607612B2 (en) | 1991-03-07 |
ZA893735B (en) | 1990-02-28 |
JPH0225422A (ja) | 1990-01-26 |
DK265789A (da) | 1989-12-02 |
DK265789D0 (da) | 1989-05-31 |
EP0344995A2 (en) | 1989-12-06 |
AU3493089A (en) | 1989-12-07 |
HUT58521A (en) | 1992-03-30 |
KR900000082A (ko) | 1990-01-30 |
EP0344995A3 (en) | 1990-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2222772B (en) | Pharmaceutical compositions | |
GB2219940B (en) | Pharmaceutical compositions | |
IL93996A0 (en) | Pharmaceutical composition containing a liposome | |
GB8825892D0 (en) | Pharmaceutical composition | |
EP0410422A3 (en) | A highly absorbable pharmaceutical composition | |
IL102372A0 (en) | Pharmaceutical composition containing a non-n-methyl-d-aspartate antagonist | |
IL87943A (en) | Pharmaceutical compositions containing a piperidinoalkanol-decongestant combination | |
IL87921A (en) | Pharmaceutical composition containing a piperidinoalkanol derivative together with calcium carbonate | |
AR243767A1 (es) | Una composicion oral antibacterial para la higiene de la boca. | |
IL90189A0 (en) | Pharmaceutical compositions containing a benzazepine-type calcium channel blocker | |
GB8814422D0 (en) | Analgesic compounds & compositions | |
ZA893422B (en) | Pharmaceutical composition | |
IL95588A0 (en) | Pharmaceutical compositions containing paf-antagonists | |
ZA89552B (en) | Pharmaceutical composition for 4-aroylimidazol-2-ones | |
AU8202287A (en) | A water-swellable composition for water-leakage prevention | |
GB2217202B (en) | Trimelamol-containing pharmaceutical compositions | |
ZA916592B (en) | A pharmaceutical composition | |
GB9018039D0 (en) | A pharmaceutical composition | |
IL89254A (en) | Pharmaceutical compositions containing diaryl compounds | |
GB8910797D0 (en) | A sealing composition | |
IE881715L (en) | Anti-bacterial oral composition containing bis-biguanido¹hexanes | |
ZA893984B (en) | Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination | |
GB8818098D0 (en) | Pharmaceutical composition | |
GB8806495D0 (en) | Pharmaceutical composition | |
GB8809849D0 (en) | Pharmaceutical composition |